Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Cardiology

Recognizing the Symptoms and Warning Signs of TGCV

At a Glance

TGCV can cause breathlessness, swelling, chest pain, reduced exercise tolerance, and abnormal heart rhythms because it affects heart muscle, coronary blood flow, and electrical signals. New severe symptoms, fainting, or persistent chest pain require emergency care.

Because Triglyceride Deposit Cardiomyovasculopathy (TGCV) is a “multi-system” metabolic disease, it often affects three major areas of the heart at the same time: the muscle’s pumping strength, the blood vessels’ supply of oxygen, and the heart’s electrical rhythm [1][2].

It is important to remember that TGCV is not caused by high cholesterol or a high-fat diet [1]. However, having normal blood triglyceride levels does not protect you from ordinary cardiovascular risks. If you have high blood pressure, high LDL cholesterol, or diabetes, these must still be treated aggressively to protect your heart.

The Three Main Ways TGCV Feels

Most patients experience symptoms in one or more of these categories:

  • Heart Failure (Energy Failure): Because the heart muscle cannot access its stored fuel, it may become weak or stiff. You might feel shortness of breath during activities that used to be easy, or you may notice swelling in your legs and ankles [1][3]. A key sign of worsening is orthopnea—needing to prop yourself up with pillows to breathe while sleeping [3].
  • Diffuse Coronary Artery Disease: Unlike “typical” heart disease where one or two spots are blocked by cholesterol plaques, TGCV often causes “diffuse” or concentric narrowing, where the entire length of the blood vessels becomes narrowed by fat deposits [1][4]. This can cause persistent chest pain (angina) [5].
  • Electrical Instability: The accumulation of fats can interfere with the heart’s electrical signals, leading to ventricular arrhythmias (irregular heartbeats starting in the lower chambers) [1][6]. This may feel like a sudden racing heart, “skipped” beats, or unexplained lightheadedness [7].

Differences Between P-TGCV and I-TGCV

While both forms affect the heart similarly, the timing and non-cardiac symptoms often differ. Note that these ages and symptoms are general trends seen in small observational cohorts, not strict diagnostic boundaries:

Feature Primary TGCV (P-TGCV) Idiopathic TGCV (I-TGCV)
Usual Age of Onset Tends to present earlier, often in the 30s [1] Tends to present later, often in the 50s [1]
Genetic Cause Confirmed pathogenic biallelic PNPLA2 mutations [1] No known diagnostic mutation found [1]
Muscle Involvement May include noticeable muscle weakness or myopathy [7] Generally limited to the heart [8]
Severity Can be very severe, sometimes requiring transplant [7] Can be severe; variable based on cohorts [8]

In P-TGCV, doctors may look for Jordans anomaly, which is the presence of visible fat droplets inside certain white blood cells under a microscope [9].

Safety First: When to Act

Because TGCV can progress or cause sudden electrical changes, you need a concrete action plan.

IMPORTANT SAFETY RULE: Your prescribed medications, like nitroglycerin for chest pain, are critical. While TGCV-related angina is sometimes difficult to treat, you must never assume your chest pain is “just the TGCV.” Always use your nitroglycerin exactly as directed.

Call Emergency Services (911 or your local equivalent) IMMEDIATELY If:

  • Chest Pain: You have new, severe, or persistent chest pain, especially if it does not improve after using prescribed nitroglycerin, spreads to your jaw/arm, or causes sweating/nausea. Do not drive yourself to the hospital [5].
  • Severe Breathlessness: Sudden or severe difficulty breathing, even while resting.
  • Fainting (Syncope): Any episode of fainting or “blacking out,” which can be a sign of a dangerous heart rhythm [7].
  • Rapid Heart Rate: A racing heart that makes you feel weak, dizzy, or confused.

Call Your Doctor the SAME DAY If:

  • You notice a sudden weight gain (e.g., 2–3 pounds / 1–1.5 kg in a day) or new swelling in your feet or ankles. Do not adjust your diuretic (water pill) dose without your doctor’s instruction.
  • You need more pillows to breathe comfortably at night.
  • Your ability to exercise or walk drops noticeably over a few days.

What Else Could It Be?

Because TGCV is rare, it is frequently confused with more common conditions. You may have been initially told you have “typical” coronary artery disease or a non-ischemic cardiomyopathy [1]. Your care team can distinguish TGCV from these by combining specific clinical criteria with advanced scans, evaluating the washout pattern on a BMIPP scan, or in rare cases by using electron microscopy to look for fat droplets in heart tissue [10][11].

Common questions in this guide

What symptoms can triglyceride deposit cardiomyovasculopathy cause?
TGCV can affect the heart’s pumping ability, blood flow, and electrical rhythm. Symptoms may include shortness of breath with activity, leg swelling, needing extra pillows to breathe, chest pain, racing or skipped beats, lightheadedness, or fainting; primary TGCV may also cause muscle weakness.
When should I call emergency services for TGCV symptoms?
Call emergency services for new, severe, or persistent chest pain, especially if it does not improve after prescribed nitroglycerin or spreads to the jaw or arm. Severe breathlessness at rest, fainting, or a rapid heartbeat with weakness, dizziness, or confusion also requires immediate help, and you should not drive yourself.
What does needing more pillows at night mean in TGCV?
Needing more pillows to breathe comfortably can be a sign that fluid is building up or heart failure is worsening. Contact your doctor the same day, and do not change your diuretic dose unless your doctor tells you to.
Can TGCV cause dangerous heart rhythms?
Yes. Triglyceride accumulation can interfere with the heart’s electrical signals and lead to ventricular arrhythmias. A racing or skipped heartbeat, lightheadedness, or fainting should be reported promptly, and your clinician can advise whether heart-rhythm monitoring is appropriate.
How are primary and idiopathic TGCV different?
Primary TGCV is associated with confirmed disease-causing changes in both copies of the PNPLA2 gene and often begins earlier, sometimes with muscle weakness. Idiopathic TGCV has no known diagnostic mutation, tends to begin later, and is generally limited to the heart; these age and symptom patterns are general trends, not strict rules.
What changes should I track at home if I have TGCV?
Track your weight, ankle or foot swelling, number of pillows needed at night, breathing, and ability to walk or exercise. Contact your doctor the same day for a rapid weight gain of about 2 to 3 pounds (1 to 1.5 kilograms) in one day, new swelling, more trouble breathing at night, or a noticeable drop in activity tolerance.

Get notified when new evidence is published on Triglyceride deposit cardiomyovasculopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Triglyceride deposit cardiomyovasculopathy: A new class of cardiovascular disease.

    Mori T, Hirano KI, Miyauchi H, et al.

    Journal of cardiology 2026; (88(4)):255-267 doi:10.1016/j.jjcc.2026.04.003.

    PMID: 41980667
  2. 2

    Long-term survival and durable recovery of heart failure in patients with triglyceride deposit cardiomyovasculopathy treated with tricaprin.

    Hirano KI, Okamura S, Sugimura K, et al.

    Nature cardiovascular research 2025; (4(3)):266-274 doi:10.1038/s44161-025-00611-7.

    PMID: 39948308
  3. 3

    Triglyceride Deposit Cardiomyovasculopathy with Massive Myocardial Triglyceride which Was Proven Using Proton-magnetic Resonance Spectroscopy.

    Sai E, Shimada K, Aikawa T, et al.

    Internal medicine (Tokyo, Japan) 2021; (60(8)):1217-1220 doi:10.2169/internalmedicine.6126-20.

    PMID: 33162485
  4. 4

    Durable Vessel Patency Achieved by Drug-Coated Balloon-Only Percutaneous Coronary Intervention in Triglyceride Deposit Cardiomyovasculopathy.

    Uchiumi K, Nakano Y, Katsuki S, et al.

    JACC. Case reports 2026; 110636 doi:10.1016/j.jaccas.2026.110636.

    PMID: 42853169
  5. 5

    1H-MRS to evaluate improved triglyceride accumulation in idiopathic triglyceride deposit cardiomyovasculopathy after CNT-01 (tricaprin/trisdecanion) administration.

    Aikawa T, Sai E, Kudo A, et al.

    Endocrinology, diabetes & metabolism case reports 2023; (2023(2)).

    PMID: 37096980
  6. 6

    Diagnostic Principle with Washout Rate of 123I-β-methyl-p-iodophenyl pentadecanoic Acid for Triglyceride Deposit Cardiomyovasculopathy.

    Hirano KI, Miyauchi H, Nakajima K

    Annals of nuclear cardiology 2025; (11(1)):39-41 doi:10.17996/anc.25-00003.

    PMID: 41368557
  7. 7

    ATGL Deficiency-Induced Triglyceride Deposit Cardiomyovasculopathy Requiring Heart Transplant: A 5-Year Follow-Up.

    Rajani P, Robertus JL, Wong J, et al.

    JACC. Case reports 2020; (2(5)):760-763 doi:10.1016/j.jaccas.2020.03.021.

    PMID: 34317343
  8. 8

    Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder.

    Li M, Hirano KI, Ikeda Y, et al.

    Orphanet journal of rare diseases 2019; (14(1)):134 doi:10.1186/s13023-019-1087-4.

    PMID: 31186072
  9. 9

    Neutral Lipid Storage Disease Associated with the PNPLA2 Gene: Case Report and Literature Review.

    Samukawa M, Nakamura N, Hirano M, et al.

    European neurology 2020; (83(3)):317-322 doi:10.1159/000508346.

    PMID: 32564019
  10. 10

    Visual Differentiation Between Triglyceride Deposit Cardiomyovasculopathy and Old Myocardial Infarction Using Count-Washout Rate Polar Map in Iodine-123-β-Methyl-p-Iodophenyl-Pentadecanoic Acid Scintigraphy.

    Ono R, Hoshi K, Miyauchi H, Kobayashi Y

    Annals of nuclear cardiology 2025; (11(1)):20-25 doi:10.17996/anc.24-00012.

    PMID: 41368555
  11. 11

    Additional diagnostic value of electron microscopic examination in endomyocardial biopsy in patients with suspected non-ischemic cardiomyopathy.

    Yamamoto M, Sato K, Murakoshi N, et al.

    Journal of cardiology 2023; (81(2)):236-243 doi:10.1016/j.jjcc.2022.09.012.

    PMID: 36182004

This page is for informational purposes only and does not constitute medical advice. It describes TGCV symptoms and warning signs; follow your prescribed chest-pain plan and contact your care team about changes in your symptoms.